3D rendering of an eye affected by central serous chorioretinopathy, showing fluid buildup under the retina.

CSC Unveiled: How 3D Scans are Revolutionizing Diagnosis and Treatment

Jordan Keane in Health & Wellness August 2025 • 4 min read.

"New research shows how detailed 3D imaging can differentiate between acute and chronic central serous chorioretinopathy, leading to better outcomes for patients."

Central serous chorioretinopathy (CSC) is an eye condition that causes fluid to build up under the retina, leading to blurred vision and visual distortions. While many cases resolve on their own, some become chronic and can cause lasting damage. Predicting the course of CSC has always been a challenge, but new technology is providing doctors with clearer insights than ever before.

Enter spectral-domain optical coherence tomography (SDOCT), a sophisticated imaging technique that allows doctors to see the retina in incredible detail. Unlike traditional methods, SDOCT can create three-dimensional (3D) reconstructions of the fluid buildup associated with CSC, offering a more comprehensive view of the condition.

A recent study published in Investigative Ophthalmology & Visual Science has harnessed the power of SDOCT to analyze the 3D configurations of subretinal fluid (SRF) in CSC patients. The findings reveal key differences between acute and chronic cases, paving the way for more accurate diagnoses and tailored treatment strategies.

Decoding the 3D Landscape of Subretinal Fluid: What the Study Revealed?

3D rendering of an eye affected by central serous chorioretinopathy, showing fluid buildup under the retina.

Researchers retrospectively reviewed OCT images from patients diagnosed with CSC, using a modified segmentation algorithm to assess the 3D configurations of SRF. By comparing these configurations in acute versus chronic CSC, the study aimed to identify markers that could predict disease progression.

The study, which included 69 eyes of 68 patients, uncovered significant differences in the 3D structure of SRF between acute and chronic CSC. While the overall volume and area of SRF were similar in both groups, key differences emerged in the fluid's peak height (PH) and its ratio to the greatest basal diameter (GBD).

Peak Height (PH): In acute CSC, the mean peak height of SRF was significantly greater than in chronic CSC (298.13 ± 92.67 µm vs. 192.97 ± 71.05 µm). This suggests that the fluid tends to accumulate more intensely in acute cases.
PH/GBD Ratio: Similarly, the ratio of peak height to greatest basal diameter was higher in acute CSC (9.44 ± 2.57% vs. 5.97 ± 1.90%). This reinforces the observation that the fluid accumulation is more concentrated in acute CSC.
Vertical Eccentricity: Chronic CSC showed greater vertical eccentricity (15.80 ± 13.66%) than acute CSC (7.10 ± 5.02%). This indicates the fluid is being pulled by gravity more in chronic cases.

Furthermore, the study explored how early changes in the 3D configuration of SRF relate to disease prognosis in acute CSC. The researchers found that the pattern of change within the first month could distinguish between cases that would spontaneously resolve and those that would persist.

The Future of CSC Diagnosis: A 3D Perspective

This groundbreaking study highlights the potential of 3D SDOCT imaging to revolutionize the diagnosis and management of CSC. By providing a more detailed understanding of the SRF configuration, doctors can better differentiate between acute and chronic cases, predict disease progression, and tailor treatment strategies for improved patient outcomes. While further research is needed to validate these findings and explore their clinical implications, the future of CSC care looks brighter than ever thanks to these advancements in imaging technology.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is Central Serous Chorioretinopathy (CSC), and how does it affect vision?

Central Serous Chorioretinopathy (CSC) is an eye condition characterized by fluid buildup under the retina. This accumulation of fluid leads to blurred vision and visual distortions. While many cases of CSC resolve spontaneously, others become chronic, potentially causing lasting damage to the retina and impacting the patient's ability to see clearly. The fluid disrupts the normal functioning of the retinal cells, leading to the visual symptoms experienced by those with CSC.

How does Spectral-Domain Optical Coherence Tomography (SDOCT) aid in understanding CSC, and what are its advantages over traditional methods?

Spectral-Domain Optical Coherence Tomography (SDOCT) is a sophisticated imaging technique that provides detailed, three-dimensional (3D) views of the retina. Unlike older methods, SDOCT allows doctors to visualize the fluid buildup associated with CSC in incredible detail. This 3D reconstruction is crucial because it offers a more comprehensive understanding of the condition, enabling the differentiation between acute and chronic cases. This detailed view aids in accurate diagnosis and personalized treatment plans, marking a significant advancement over traditional methods.

What specific differences in Subretinal Fluid (SRF) configurations did the study reveal between acute and chronic CSC using 3D SDOCT?

The study using 3D SDOCT revealed notable differences in Subretinal Fluid (SRF) configurations between acute and chronic CSC. In acute CSC, the mean Peak Height (PH) of SRF was significantly greater than in chronic CSC. Also, the ratio of Peak Height to Greatest Basal Diameter (PH/GBD) was higher in acute cases. Vertical Eccentricity was greater in chronic CSC. These differences suggest that fluid accumulates more intensely and is more concentrated in acute cases, while in chronic cases, the fluid's distribution is affected by gravity, providing valuable insights into the progression of the disease.

How can the 3D configuration of Subretinal Fluid (SRF) help predict the prognosis of acute CSC cases?

The study found that changes in the 3D configuration of Subretinal Fluid (SRF) within the first month of diagnosis could distinguish between acute CSC cases that would spontaneously resolve and those that would persist. This early insight into the fluid's behavior provides doctors with a valuable tool for predicting the disease's course. By understanding the patterns of SRF change, they can anticipate whether the patient's condition is likely to improve on its own or if more aggressive interventions are required. This predictive capability is a significant step toward personalized patient management.

What are the potential implications of these 3D imaging advancements for the future of CSC diagnosis and treatment?

The advancements in 3D imaging, particularly using SDOCT, offer several promising implications for the future of CSC diagnosis and treatment. By providing a detailed understanding of the Subretinal Fluid (SRF) configuration, doctors can differentiate between acute and chronic cases more accurately. This allows for tailored treatment strategies, improving patient outcomes. This technology aids in predicting disease progression. While more research is necessary, these advancements signal a shift towards more effective and personalized care for individuals with CSC, potentially leading to earlier interventions and better long-term visual outcomes.